IL1B and retinitis pigmentosa 1: Clinical evidence reported after these guidelines had been published showed that IL-1α and IL-1β mediate the pathophysiology of RP through the inappropriate induction and activation, respectively, of the innate immune system in a self-perpetuating cycle of autoinflammation.13